Life Sci. 2020 Jan 29
Targeted lipidomics and transcriptomics profiling reveal the heterogeneity of visceral and subcutaneous white adipose tissue.
Hou B, Zhao Y, He P, Xu C, Ma P, Lam SM, Li B, Gil V, Shui G, Qiang G, Liew CW, Du G
The depot-specific differences in lipidome of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reflect heterogeneity of white adipo ...
Read More
Source: PubMed
Endocrine 2020 Jan 31
Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes.
Si Y, Shen Y, Lu J, Ma X, Zhang L, Mo Y, Lu W, Zhu W, Bao Y, Hu G, Zhou J
The association between ß-cell function and glycemic variability remains to be clarified in insulin-treated patients with type 2 diabetes. Therefore, ...
Read More
Source: PubMed
Sci Rep
Practical application of short-term intensive insulin therapy based on the concept of "treat to target" to reduce hypoglycaemia in routine clinical site.
Nakashima K, Okamura N, Sanefuji H, Kaneto H
The aim is to devise a new short-term intensive insulin therapy (N-SIIT) based on the concept of "treat to target" to avoid hypoglycaemia and was appl ...
Read More
Source: PubMed
Diabetes Technol. Ther. 2020 Jan 31
Increased time in range and improved insulin adherence after introduction of a smart connected insulin pen.
Adolfsson P, Hartvig NV, Kaas A, Møller JB, Hellman J
This observational study investigated whether the connected NovoPen<sup>®</sup> 6 could influence insulin regimen adherence and glycemic control in pa ...
Read More
Source: PubMed
Pediatr Diabetes 2020 Jan 31
Accuracy Assessment of Bolus and Basal Rate Delivery of Different Insulin Pump Systems Used in Insulin Pump Therapy of Children and Adolescents.
Ziegler R, Waldenmaier D, Kamecke U, Mende J, Haug C, Freckmann G
Continuous subcutaneous insulin infusion (CSII) is commonly used in patients with diabetes. Accurate and reliable delivery by insulin pumps is essenti ...
Read More
Source: PubMed
